- Home
- SXTP vs HSDT Comparison
SXTP vs HSDT Comparison
Compare SXTP & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- HSDT
- Stock Information
- Founded
- SXTP 2010
- HSDT 2014
- Country
- SXTP United States
- HSDT United States
- Employees
- SXTP N/A
- HSDT N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SXTP Health Care
- HSDT Health Care
- Exchange
- SXTP Nasdaq
- HSDT Nasdaq
- Market Cap
- SXTP 1.6M
- HSDT 1.8M
- IPO Year
- SXTP 2023
- HSDT N/A
- Fundamental
- Price
- SXTP $0.90
- HSDT $0.46
- Analyst Decision
- SXTP Hold
- HSDT Buy
- Analyst Count
- SXTP 1
- HSDT 2
- Target Price
- SXTP N/A
- HSDT $24.00
- AVG Volume (30 Days)
- SXTP 87.9K
- HSDT 116.7K
- Earning Date
- SXTP 11-26-2024
- HSDT 11-12-2024
- Dividend Yield
- SXTP N/A
- HSDT N/A
- EPS Growth
- SXTP N/A
- HSDT N/A
- EPS
- SXTP N/A
- HSDT N/A
- Revenue
- SXTP $462,612.00
- HSDT $502,000.00
- Revenue This Year
- SXTP $267.05
- HSDT $16.41
- Revenue Next Year
- SXTP $181.82
- HSDT $31.97
- P/E Ratio
- SXTP N/A
- HSDT N/A
- Revenue Growth
- SXTP 12.07
- HSDT N/A
- 52 Week Low
- SXTP $0.70
- HSDT $0.37
- 52 Week High
- SXTP $18.36
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- SXTP 47.11
- HSDT 39.76
- Support Level
- SXTP $0.87
- HSDT $0.44
- Resistance Level
- SXTP $1.14
- HSDT $0.58
- Average True Range (ATR)
- SXTP 0.12
- HSDT 0.06
- MACD
- SXTP 0.02
- HSDT 0.00
- Stochastic Oscillator
- SXTP 53.88
- HSDT 4.17
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.